@FierceMedDev: Elixir snags CE mark for dissolvable stent. News | Follow @FierceMedDev
@MarkHFierce: Roche won crucial FDA approval for a companion diagnostic for lung cancer. Goes with Astellas' Tarceva. Release | Follow @MarkHFierce
@DamianFierce: Analogic is lopping off 140 jobs in Colorado and Vancouver. More | Follow @DamianFierce
> Patients implanted with pricey dual-chamber ICDs experienced no added benefits but suffered higher rates of complications than those fitted with single-chamber devices, according to a new study. Article
> Chinese police have arrested 14 people accused of selling smuggled, second-hand medical devices to clinics. Story
> Illumina ($ILMN) is teaming up with robotics makers to develop automation technology for its gene sequencing kits, announcing partnerships with Beckman Coulter Life Sciences, Eppendorf, Hamilton Robotics, PerkinElmer, and Tecan. News
> Agilent's ($A) diagnostics business, fueled by Dako, grew 124% last quarter, but the company's total revenue dropped 8% to $1.69 billion while net income fell about 45% to $166 million. Results
> Diagnostics outfit Sysmex signed a 5-year deal with the U.S. Department of Veterans Affairs to supply its XN-Series blood analyzers VA hospitals. More
> South Carolina and Israeli companies and universities will partner on a variety of R&D projects, likely including biomedical initiatives. Story
> Australia's Global Orthopaedic Technology gained the FDA's 510(k) clearance to market and sell its Paragon hip replacement system. Story
Biotech News
@FierceBiotech: $VVUS announces proposed offering of convertible senior notes. Release | Follow @FierceBiotech
@JohnCFierce: Quintiles joins Merck KGaA's R&D command post in 5-year exclusive. News | Follow @JohnCFierce
@RyanMFierce: Billionaires back Kite Pharma in $20M raise for cancer immunotherapies. Article | Follow @RyanMFierce
> FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta. News
> New crowdfunding platform set to launch new biotechs. More
> Tokai lands $35M venture round for triple-threat prostate cancer drug. News
Pharma News
@FiercePharma: ICYMI - Merck execs' bogeymen: Animal-rights extremists, disease activists and laid-off workers, security tells FAA. Report | Follow @FiercePharma
> Roche wins new targeted OK for Tarceva in EGFR-positive lung cancer. News
> U.K. saves £1 million a day, thanks to generic Lipitor. News
> Actavis nixed a $15B offer from Mylan to zero in on Warner Chilcott . Article
Drug Delivery News
@MichaelGFierce: Israeli team spurs nerve healing with implant-released gel. More | Follow @MichaelGFierce
> New polymers shatter to release drugs at specific target. Report
> Marina platform to deliver first-ever miRNA cancer drug for Mirna PhI. News
> Scripps study reveals new RNA-drug targeting potential. Article
> FDA accepts Merck's sublingual allergy med license application. Item
Biomarkers News
> Genome mutations reveal acute myeloid leukemia risk, potential drug targets. Story
> Biomarker trio enables blood Dx to map heart attack risk. More
> Bristol-Myers Squibb, Adaptive Biotechnologies ally for cancer biomarker development. More
> Fetus secretes hormone that could flag preeclampsia risk. Article
> 9 blood-based biomarkers correspond to amyloid plaque in the brain. Item